Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
HIV associated nephropathy epidemiology and demographics
Introduction
Overview
Overview
HIV-associated nephropathy (HIVAN) is mostly seen in male patients and of African decent. The prevalence of HIVAN in the population of patients with African descent has been reported to be 3% to 12%.[1]
Epidemiology
Epidemiology
The prevalence of HIV-associated nephropathy (HIVAN) in the population of patients with African descent has been reported to be 3% to 12%.[1]
Demographics
Demographics
Age
The average age at which patients are affected with HIV-associated nephropathy has been reported to be around 40.8 years of age in a study.[2]
Gender
HIV-associated nephropathy affects men more than women.[2]
Race
HIVAN is mostly seen in patients of African descent.[2]
References
References
- ↑ 1.0 1.1 Menez S, Hanouneh M, McMahon BA, Fine DM, Atta MG (2018). “Pharmacotherapy and treatment options for HIV-associated nephropathy”. Expert Opin Pharmacother. 19 (1): 39–48. doi:10.1080/14656566.2017.1416099. PMC 6381591. PMID 29224373.
- ↑ 2.0 2.1 2.2 Atta MG, Lucas GM, Fine DM (2008). “HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management”. Expert Rev Anti Infect Ther. 6 (3): 365–71. doi:10.1586/14787210.6.3.365. PMID 18588500.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[3]Krzysztof Wierzbicki M.D. [4]